Deutsche Biotech Innovativ AG Logo

Deutsche Biotech Innovativ AG

DBI | FRA

Overview

Corporate Details

ISIN(s):
DE000A0Z25L1
LEI:
391200BIDNL2ZOKI1M61
Country:
Germany
Address:
Neuendorfstraße 15a, 16761 Hennigsdorf
Sector:
Health Care
Industry:
Biotechnology

Description

Deutsche Biotech Innovativ (DBI) AG is a listed biotechnology company based in Hennigsdorf near Berlin. The DBI share (DE000A0Z25L1) is traded over-the-counter on the Düsseldorf Stock Exchange. Since fall 2017, the DBI share has also been listed on the Frankfurt Stock Exchange and the Berlin Stock Exchange. DBI AG was founded in 2009 as Venetus Beteiligungen AG. The company was renamed Deutsche Biotech Innovativ AG in August 2014. DBI invests in biotechnology companies that pursue an innovative research and development approach and develop drug candidates with a high unique selling proposition.

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2022-04-21 10:27
Regulatory News Service
Deutsche Biotech Innovativ AG: Paul-Ehrlich Institut-(PEI)-Zulassung fur eine d…
German 33.0 KB
2021-02-04 20:01
Board/Management Change
Deutsche Biotech Innovativ AG: Veranderungen in Vorstand und Aufsichtsrat
German 5.4 KB
2020-09-16 06:30
Regulatory News Service
Deutsche Biotech Innovativ AG: * Positive Ergebnisse der Phase-II-Studie Adreno…
German 6.5 KB
2020-08-25 10:58
Regulatory News Service
Deutsche Biotech Innovativ AG: Barrier function of blood vessels as therapeutic…
English 7.5 KB
2020-08-19 14:00
Regulatory News Service
Deutsche Biotech Innovativ AG: Further step towards a strong capital market ori…
English 7.6 KB
2020-08-19 09:15
Regulatory News Service
Deutsche Biotech Innovativ AG: Erste Investition in das Biomarker-Unternehmen S…
German 7.6 KB
2020-07-21 10:00
Regulatory News Service
Deutsche Biotech Innovativ AG: Shares admitted to Xetra trading, Baader Bank AG…
English 6.2 KB
2020-06-04 10:00
Board/Management Change
Deutsche Biotech Innovativ AG: Ralf M. Jakobs neuer CFO der DBI AG
German 6.6 KB
2020-02-25 11:07
Regulatory News Service
Deutsche Biotech Innovativ AG: Beteiligungsunternehmen AdrenoMed AG verkundet…
German 6.4 KB
2020-02-21 14:02
Earnings Release
Bekanntgabe von positiven Ergebnissen der klinischen Phase II Studie AdrenOSS-2…
German 4.5 KB
2019-09-30 13:30
Board/Management Change
Deutsche Biotech Innovativ AG: Beteiligungsunternehmen AdrenoMed AG
German 8.5 KB
2019-03-22 12:30
Regulatory News Service
Deutsche Biotech Innovativ AG: Beteiligungsunternehmen AdrenoMed AG veroffentli…
German 8.3 KB
2018-11-23 19:30
Regulatory News Service
- Kapitalerhohung bei Tochtergesellschaft AdrenoMed AG: Mittelzufluss von rd. …
German 5.4 KB
2018-07-10 09:30
Regulatory News Service
DBI AG mit Zweitlisting in Frankfurt; DBI Wechsel im Aufsichtsrat; Adrenomed: W…
German 10.5 KB
2017-08-16 17:04
Share Issue/Capital Change
Deutsche Biotech Innovativ AG: Kapitalerhohung
German 7.8 KB

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo 1NKEMIA Spain IKM
2cureX AB Logo 2cureX AB Sweden 2CUREX
4SC AG Logo 4SC AG Germany VSC
Abera Bioscience AB Logo Abera Bioscience AB Sweden ABERA
ABIONYX Pharma Logo ABIONYX Pharma France ABNX
Abliva Logo Abliva Sweden ABLI
AB Science Logo AB Science France AB
Acticor Biotech Logo Acticor Biotech France ALACT
Active Biotech Logo Active Biotech Sweden ACTI
AcuCort AB Logo AcuCort AB Sweden ACUC